TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A Swedish registry study found that children whose parents had autoimmune diseases faced higher rates of type 1 diabetes, with the strongest associations when a parent had type 1 diabetes. The findings show a family-linked risk pattern, but do not establish that parental disease causes diabetes in children or specify an individual child’s likelihood.
A Swedish registry study of 1,455,645 children found that offspring of parents with autoimmune diseases had higher rates of type 1 diabetes, with the strongest associations among children whose mother or father had type 1 diabetes. The findings, published in JAMA Pediatrics, point to a familial pattern of risk but do not show that a parent’s condition causes diabetes in a child.
Children whose mothers had an autoimmune disease before delivery had a 57% higher risk of developing type 1 diabetes than children whose mothers did not, based on the study’s adjusted estimate (hazard ratio 1.57; 95% confidence interval 1.46–1.68). The corresponding estimate for paternal autoimmune disease before childbirth was similar: a 51% higher risk (hazard ratio 1.51; 95% CI 1.37–1.67).
The estimates were larger when a parent had type 1 diabetes specifically. Maternal type 1 diabetes was associated with a hazard ratio of 4.51 (95% CI 3.72–5.48), while paternal type 1 diabetes was associated with a hazard ratio of 5.79 (95% CI 4.70–7.13). The researchers reported the highest risk among children whose both parents had type 1 diabetes, though the supplied report does not give a numerical estimate for that group.
The team, led by Xingbo Mo of Karolinska Institutet, studied children born in Sweden from 2001 to 2014 and tracked outcomes through 2023. Median age at follow-up was 15.3 years. In cousin-comparison analyses intended to account for shared familial factors, the association with maternal autoimmune disease remained statistically significant but was smaller: hazard ratio 1.27 (95% CI 1.08–1.50).
How Family History Shapes Risk
The findings may help clinicians and families understand that type 1 diabetes risk is associated with a broader family history of autoimmune disease, not only a parent’s diagnosis of type 1 diabetes. The markedly higher estimates for parental type 1 diabetes reinforce that a child with an affected parent belongs to a group with elevated risk, although the study does not predict whether any particular child will develop the condition.
In an accompanying editorial, Mikael Knip of Biomedicum Helsinki said children of parents with autoimmune disease warrant attention for possible type 1 diabetes. He noted that consensus guidance exists for screening and monitoring people at risk, while access and screening practices can vary with available resources. The results could inform discussions about who may benefit from monitoring, but the study itself did not test a screening strategy or show that screening improves outcomes.
The research also highlights the complexity of inherited risk. Benjamin Nwosu, an endocrinologist at Northwell Health Cohen Children’s Medical Center who was not involved in the study, said type 1 diabetes involves multiple genes rather than a simple inheritance pattern. The associations should be understood as differences in risk across groups, not as certainty that a child will inherit the disease.
Products Worth Considering
Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor
Garmin Venu® 3 Premium Fitness Smartwatch 45mm Black
Therabody Theragun Mini 3rd Gen Massage Gun (Travel Essential, Black)
As an affiliate, we earn on qualifying purchases.
What the Swedish Study Measured
The cohort included nearly 1.5 million children born in one country over 14 years, giving researchers a large population in which to compare parental diagnoses with later type 1 diabetes in offspring. The study considered maternal autoimmune disease before delivery and paternal disease before childbirth, and used adjusted statistical models to estimate associations.
Results varied by disease category. The researchers reported stronger paternal associations for endocrine autoimmune conditions, especially autoimmune thyroiditis, while maternal associations were stronger for ankylosing spondylitis and gastrointestinal autoimmune disorders. They said this variation could reflect different forms of shared susceptibility or possible effects related to pregnancy, but the study cannot determine which mechanisms account for the patterns.
Nwosu cautioned that findings from Sweden may not transfer directly to other populations, describing the country’s northern latitude as a factor relevant to its high burden of type 1 diabetes. The study’s population and registry design provide evidence about associations in Sweden; they do not establish that estimates will be identical elsewhere.
“A clear gradient in type 1 diabetes risk was observed according to parental type 1 diabetes status, with the highest risk among offspring with both parents affected.”
— Xingbo Mo and colleagues, the study authors
Limits on Interpreting the Risk
The study found associations, not proof of causation. Researchers did not have registry information on the severity of parental disease, autoantibody levels, disease activity during pregnancy, or medication use. They said those factors could affect fetal immune programming but could not be evaluated.
The cousin-comparison analysis reduced the maternal association from the main estimate, suggesting shared family factors may account for part of the observed link. Although the adjusted association remained statistically significant, the analysis does not isolate a single biological or environmental cause. The supplied report also does not provide absolute risk figures for children with and without affected parents, so the hazard ratios should not be read as an individual child’s probability of developing diabetes.
It remains unclear how well the findings apply to populations outside Sweden, whether disease severity or treatment changes the associations, and which children would benefit from particular screening schedules. The study did not assess screening outcomes or recommend a new protocol.
How Screening Guidance May Apply
The study authors called for attention to the different patterns seen across autoimmune disease categories and for further work to clarify potential familial and pregnancy-related influences. The next questions include whether these associations appear in other populations and whether more detailed clinical data change the estimates.
Knip pointed to existing consensus guidance for screening and monitoring people considered at risk, while acknowledging that implementation may vary by resources. The report does not announce a change to those guidelines. Families concerned about inherited risk can discuss personal history and appropriate monitoring with a qualified health professional; the study does not establish a screening schedule for an individual child.
Key Questions
Does a parent’s autoimmune disease cause type 1 diabetes in a child?
No. The study found associations between parental autoimmune disease and higher rates of type 1 diabetes in offspring. It did not establish that the parent’s condition causes the child’s diabetes.
Which parental diagnosis had the strongest reported association?
Among the estimates provided, paternal type 1 diabetes had the highest hazard ratio, at 5.79. Maternal type 1 diabetes had a hazard ratio of 4.51. These are relative hazard estimates, not a child’s absolute probability of developing the condition.
How many children were included?
The researchers studied 1,455,645 children born in Sweden between 2001 and 2014, with follow-up through 2023.
Does the study recommend screening every child with an affected parent?
The study did not test a screening plan or issue a new recommendation. An accompanying editorial said children of parents with autoimmune disease warrant monitoring and referred to existing consensus guidance; families should discuss individual questions with a qualified health professional.
What important information was missing?
The researchers lacked data on parental disease severity, autoantibody levels, disease activity during pregnancy, and medication use. They also cautioned that results from Sweden may not apply in the same way to every population.
Source: medpagetoday.com
